PrognosDx Health, Inc. - Product Pipeline Analysis, 2015 Update

Date: June 24, 2015
Pages: 22
Price:
US$ 750.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: PE5D4E17EC2EN
Leaflet:

Download PDF Leaflet

PrognosDx Health, Inc. - Product Pipeline Analysis, 2015 Update
Summary

PrognosDx Health, Inc. (PrognosDx) is a biotechnology company that develops products for the treatment of cancer and other complex diseases. The company's products include prognoscore and rxscore. PrognosDx’s prognoscore is used in the treatment of prostate cancer and bladder cancer. The company’s rxscore is a therapeutic test for pancreatic, breast, colorectal and lung cancers. It also provides molecular signatures specific to each individual cancer patient’s disease. PrognosDx provides services to 12 major cancers including breast, ovarian, glioma, pancreatic, liver, colorectal, gastric, lung, kidney, bladder, prostate and leukemia. The company conducts clinical validation studies at medical centers throughout the US. PrognosDx is headquartered in Sunny Vale, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company PrognosDx Health, Inc.
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.

    Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
  • PrognosDx Health, Inc. Company Snapshot
    PrognosDx Health, Inc. Company Overview
    Key Information
    PrognosDx Health, Inc. Pipeline Products and Clinical Trials Overview
    PrognosDx Health, Inc. – Pipeline Analysis Overview
    Key Facts
    PrognosDx Health, Inc. - Major Products and Services
    PrognosDx Health, Inc. Pipeline Products by Development Stage
    PrognosDx Health, Inc. Pipeline Products Overview
    PrognoScore Test - Bladder Cancer
    PrognoScore Test - Bladder Cancer Product Overview
    PrognoScore Test - Prostate Cancer
    PrognoScore Test - Prostate Cancer Product Overview
    RxScore Therapeutic Response Test - Breast Cancer
    RxScore Therapeutic Response Test - Breast Cancer Product Overview
    RxScore Therapeutic Response Test - Colorectal Cancer
    RxScore Therapeutic Response Test - Colorectal Cancer Product Overview
    RxScore Therapeutic Response Test - Lung Cancer
    RxScore Therapeutic Response Test - Lung Cancer Product Overview
    RxScore Therapeutic Response Test - Pancreatic Cancer
    RxScore Therapeutic Response Test - Pancreatic Cancer Product Overview
    PrognosDx Health, Inc. - Key Competitors
    PrognosDx Health, Inc. - Key Employees
    PrognosDx Health, Inc. - Locations And Subsidiaries
    Head Office
    Recent Developments
    PrognosDx Health, Inc., Recent Developments
    Oct 24, 2013: PrognosDx Board of Directors Appoints Joseph J. Vallner, Ph.D. as Chief Executive Officer and Member of the Board of Directors
    Mar 30, 2011: PrognosDx Health Elects A Franklin Rice To Board Of Directors
    Appendix
    Methodology
    About GlobalData
    Contact Us
    Disclaimer

    LIST OF TABLES

    PrognosDx Health, Inc., Key Facts
    PrognosDx Health, Inc. Pipeline Products and Clinical Trials Overview
    PrognosDx Health, Inc. Pipeline Products by Equipment Type
    PrognosDx Health, Inc. Pipeline Products by Indication
    PrognosDx Health, Inc., Key Facts
    PrognosDx Health, Inc., Major Products and Services
    PrognosDx Health, Inc. Number of Pipeline Products by Development Stage
    PrognosDx Health, Inc. Pipeline Products Summary by Development Stage
    PrognoScore Test - Bladder Cancer - Product Status
    PrognoScore Test - Bladder Cancer - Product Description
    PrognoScore Test - Prostate Cancer - Product Status
    PrognoScore Test - Prostate Cancer - Product Description
    RxScore Therapeutic Response Test - Breast Cancer - Product Status
    RxScore Therapeutic Response Test - Breast Cancer - Product Description
    RxScore Therapeutic Response Test - Colorectal Cancer - Product Status
    RxScore Therapeutic Response Test - Colorectal Cancer - Product Description
    RxScore Therapeutic Response Test - Lung Cancer - Product Status
    RxScore Therapeutic Response Test - Lung Cancer - Product Description
    RxScore Therapeutic Response Test - Pancreatic Cancer - Product Status
    RxScore Therapeutic Response Test - Pancreatic Cancer - Product Description
    PrognosDx Health, Inc., Key Employees

    LIST OF FIGURES

    PrognosDx Health, Inc. Pipeline Products by Equipment Type
    PrognosDx Health, Inc. Pipeline Products by Development Stage
    Skip to top


    Ask Your Question

    PrognosDx Health, Inc. - Product Pipeline Analysis, 2015 Update
    Company name*:
    Contact person*:
    Phone/fax*:
    Email*:
    Request invoice
    Your enquiry:
    Please click on a Check Box below to confirm you are not a robot: